News & Events

Latest News

September 2020

TILT Biotherapeutics announces two patients pass primary safety endpoint in European cancer immunotherapy trial

June 2020

Press Release: TILT Biotherapeutics secures over EUR 6 million to advance cancer immunotherapies into clinic

May 2020

Tuija Keinonen joins TILT as Regulatory consultant

April 2020

TILT Biotherapeutics was featured Tulevaisuuden työelämä 2020. Read the article in Finnish here.

April 2020

TILT´s CEO Akseli Hemminki interviewed at JP Morgan Biotech Showcase

March 2020

TILT varautuminen koronatilanteen aiheuttamiin muutoksiin

March 2020

TILT preparations during the corona pandemic

March 2020

Jyrki Liljeroos joins TILT as Board Advisor

March 2020

Springvest organised investment round

February 2020

João Santos appointed as a Head of Cell Therapy

January 2020

TILT Biotherapeutics Signs a Licensing Deal with Biotheus, Inc

Upcoming Events

Please contact our business development team to meet us at the following events:

October 2020

BioEurope Digital, 26-29th October 2020

Location: Virtual meeting

November 2020

Investival Showcase Virtual, 11-16 November 2020

Location: Virtual meeting

January 2021

Biotech Showcase Digital, 11-15th January 2020

Location: Virtual meeting

January 2021

ESCGT/BSCGT, Edinburgh EICC, 19 -22 January 2021

Location: Virtual meeting